Kazia Therapeutics Ltd (KZIA)
0.26
+0.01
(+4.12%)
USD |
NASDAQ |
May 31, 16:00
0.254
-0.01
(-2.31%)
After-Hours: 20:00
Kazia Therapeutics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 0.0094M |
| September 30, 2021 | -1.162M |
| December 31, 2020 | 0.00 |
| September 30, 2020 |
| Date | Value |
|---|---|
| December 31, 2007 | 3.358M |
| December 31, 2006 | -0.1808M |
| December 31, 2005 | -0.1248M |
| December 31, 2004 | -0.1779M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.162M
Minimum
Sep 2021
0.0094M
Maximum
Dec 2021
-0.3841M
Average
--
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
| Immutep Ltd | -- |
| Opthea Ltd | -- |
| Alterity Therapeutics Ltd | -- |
| Mesoblast Ltd | 0.016M |
| Immuron Ltd | -- |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | -8.366M |
| Free Cash Flow Yield | -139.1% |